Our present study revealed that Chfr promoter hypermethylation appears to be one of the most cancer-specific alterations among the various examples of tumour suppressor and tumour-related gene hypermethylation reported to date (Tamura, 2004). The gene discussed is CHFR; the disease is neoplasm.